Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Asthma nebulizer showdown: which mode delivers best?

NCT ID NCT07633223

Knowledge-focused Sponsor: Beni-Suef University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested different ways to use a nebulizer for asthma medication. 36 people with mild to moderate asthma received the drug salbutamol through various nebulization modes. The goal was to see which mode delivers more medication to the lungs and reduces waste. Results could help doctors recommend the most effective nebulizer settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
salbutamol
What this could lead to
If this trial succeeds, it could lead to better guidelines on how to use nebulizers for asthma, improving drug delivery to the lungs.
What could go wrong
This is a small, completed Phase 4 trial with only 36 participants. It focuses on delivery methods, not a new treatment, so the impact on patient health may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

36 people

The number who actually took part.

Started

Sep 2024

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Mild to moderate asthmatic patients. Exclusion Criteria: * Severe asthmatic patients. * Patients admitted to an intensive care unit * Ischemic heart disease. * Recent abdominal surgery. * Hepatic or renal impairment. * Hypersensitivity to salbutamol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aerosol therapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aerosol therapy Asthma

Contacts and locations

Locations

  • Beni-Suef University Hospital

    Banī Suwayf, Beni Suweif Governorate, 62511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.